Loading...
XNAS
MTLS
Market cap344mUSD
Dec 05, Last price  
5.84USD
1D
-2.18%
1Q
17.98%
Jan 2017
-23.96%
IPO
-50.92%
Name

Materialise NV

Chart & Performance

D1W1MN
XNAS:MTLS chart
P/E
22.05
P/S
1.11
EPS
0.23
Div Yield, %
Shrs. gr., 5y
1.83%
Rev. gr., 5y
6.29%
Revenues
267m
+4.15%
59,107,00068,723,00081,355,000102,035,000114,477,000142,573,000184,721,000196,679,000170,449,000205,450,000232,023,000256,127,000266,765,000
Net income
13m
+99.88%
1,551,0003,509,0002,061,000-2,807,000-3,019,000-1,656,0003,027,0001,646,000-7,271,00013,154,000-2,153,0006,722,00013,436,000
CFO
31m
+56.05%
6,114,0008,881,0004,839,0003,667,0008,495,0009,886,00028,321,00028,402,00029,976,00025,843,00024,709,00020,157,00031,456,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Materialise NV provides additive manufacturing and medical software, and 3D printing services in the Americas, Europe and Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. Its Materialise Software segment offers software through programs and platforms that enable and enhance the functionality of 3D printers and of 3D printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, Website, and third-party distributors. The company's Materialise Medical segment provides medical software that allows medical-image based analysis and engineering, as well as patient-specific design of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies through its direct sales force, Website, and picture archiving and communication system partners. Its Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to industrial and commercial customers. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.
IPO date
Jun 25, 2014
Employees
2,439
Domiciled in
BE
Incorporated in
BE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT